Successfully developed innovative drugs

"Old He, this is what you deserve. Do your research. You may be unknown now, but you will be famous in the future. I believe you can do it."

Ye Cheng patted He Yiping on the shoulder.

"I don't want to be famous worldwide; I just hope that my research results can benefit people's livelihood and society, and that's enough," He Heping said with a smile.

"Okay, I won't disturb your research anymore. I will solve the problem of the experimental assistant for you as soon as possible," Ye Cheng said.

Then he left the second laboratory and went to the first laboratory to inquire about the experimental process.

This laboratory has several technical masters, all of whom were hired by Ye Cheng with high salaries.

There is no way to engage in lithium battery research; it is impossible without technical reserves, so it can only be done by recruiting skilled individuals.

At this moment, Ye Cheng's cell phone rang.

Ye Cheng let the researcher continue with his own work while he went to the next office and answered the phone.

The call was from Guo Changqing.

He is Ye Cheng's representative at Xinhe Pharmaceutical.

"Mr. Ye... It's great news; Xinhe Pharmaceutical's innovative drug codenamed TG5781 has been successfully developed." Guo Changqing's voice was full of excitement.

"TG5781? Are you sure it's an innovative drug with this code name?" Ye Cheng was stunned, and he almost burst into laughter.

Because he clearly remembers the innovative drug with this code name, which is a special drug specifically used to treat diabetes.

In the past, when this medicine came out, it caused a great sensation in the field of medicine, which helped many people who were seriously ill with diabetes greatly relieve their condition.

For patients with normal conditions, as long as they insist on taking this drug, there will be almost no recurrence, and the blood sugar can be stabilized within the standard value.

It can be said that the emergence of this drug has benefited nearly 100 million diabetic patients nationwide.

"Yes, Mr. Ye, that's the medicine," Guo Changqing said with certainty.

"Okay, pay close attention, and let me know as soon as there is anything," Ye Cheng said.

"Yes, Mr. Ye," Guo Changqing said quickly.

After Ye Cheng hung up the phone, he sat in the office with an uncontrollable smile on his face.

I originally thought that the success of this innovative drug might take a while, but I didn't expect to surprise myself so quickly.

Xinhe Pharmaceutical, in the conference room.

One after another, directors and senior executives came in.

Everyone had a smile and happiness on their faces.

Because good news came from the laboratory in the morning, the innovative drug represented by TG5781 has made breakthrough progress.

Originally, Ye Cheng's capital injection solved the short-term funding problem for Xinhe Pharmaceutical, and now key innovative drugs have been successfully developed. For Xinhe Pharmaceutical, it is double happiness.

The predicament and crisis of Xinhe Pharmaceutical are almost resolved.

Nangong Xiang was sitting at the conference table in a complicated mood.

If the innovative drug code TG5781 was successfully developed earlier, they would have to pay much less equity.

But it's just so unfortunate...

He sighed in his heart, saying that Ye Cheng's luck was really good.

I just injected capital and obtained 39% of the shares, and soon there will be successful research and development of new innovative drugs.

This is luck.

Unparalleled luck.

However, he was only slightly emotional, and the time is also fate, and no one can blame anyone.

What's more, Ye Cheng strongly requested to continue the research and development of the innovative drug code-named TG5781. Without Ye Cheng's persistence, the research and development of this project would have stopped.

Some time ago, he was worried that Xinhe Pharmaceutical was going to liquidate and go bankrupt.

Now that all the hardships and joys have come, the willows are dark and the flowers are bright... It should be a very happy thing.

After all the directors and executives arrived, Nangong Xiang began to discuss the next strategic direction of the company.

With the successful research and development of innovative drugs, the next step is to make adjustments and layout... Seize this opportunity to completely transform the company's existing situation.

The following day, Xinhe Pharmaceutical hosted a press conference, announcing the successful development of a crucial new drug, which immediately sent shockwaves through the medical community.

On that very day, numerous investment firms called to inquire about the situation, indicating their intent to inject capital.

However, Xinhe Pharmaceutical received an injection of capital from Ye Cheng, ensuring sufficient fund flow in the short term.

Furthermore, the bank confirmed that loan recovery would be postponed indefinitely.

Even some material suppliers expressed a willingness to suspend arrears and continue supplying.

Overnight, Xinhe Pharmaceutical was transformed from a state of isolation and helplessness.

Moreover, the delisted stocks of Xinhe Pharmaceutical saw their first daily limit on the New Third Board.

Shashi, Coriander Investment.

This is Jiaguishu Company, the general manager. Yuan, formerly of Gaosheng Company on Huaer Street, Miramar, has remarkable investment experience.

Upon returning to China, he collaborated with several business leaders to establish Qianqian Investment.

Despite being only five years old, its annual return on investment has reached an astonishing 60%.

While it may not seem significant, Qian Qian's investment capacity is formidable enough to be intimidating.

In a bright and spacious office.

"Mr. Li, this is the latest update from Xinhe Pharmaceutical."

A secretary handed Li Xiyuan an information retrieval document.

After perusing it, Li Xiyuan furrowed his brows, massaged his temples, and reclined in his chair.

"I never anticipated hesitating for a moment would cause me to miss such a golden opportunity."

He sighed.

Having been in contact with Xinhe Pharmaceutical himself and even contemplating investment plans, he realized that the substantial amount of money required to extricate Xinhe Pharmaceutical from its predicament would be detrimental to his investment firm if it incurred significant losses.

It was too risky.

Thus, he decided against it.

Little did he expect someone to be so audacious as to take the gamble.

I also won the bet.

"Chenyuan Investment, Ye Cheng... I didn't expect there would be such a prominent figure in the investment world," Li Xiyuan muttered to himself.

Then he said in a deep voice, "Find me the information about Chenyuan Investment and Ye Cheng."

"Yes, Mr. Li," the secretary responded promptly.

With the efficiency of Qian Qian's investment team, it wasn't particularly challenging to investigate the information of another investment company.

In just half an hour, a detailed document appeared on Li Xiyuan's desk.

"No wonder it's so familiar; even the Heizhou Cobalt Mine project was funded by this reputable investment firm," Li Xiyuan exclaimed in amazement.

Because Chenyuan Investment proved to be even more formidable than he had imagined. Whether it was the Heishan Cobalt Mine Project or the capital injection into Xinhe Pharmaceutical, they were risky ventures, yet Chenyuan Investment emerged victorious.

The rewards obtained were unmatched.

Although he had been involved in several highly successful investment cases, they still paled in comparison.

"I wonder if this Chenyuan investment company dares to invest in that project." Li Xiyuan pondered for a moment, an idea forming in his mind.

He recently came across an investment project that he believed would yield significant returns, but due to its high risk, he hesitated to proceed alone.

So he planned to involve other investment firms and distribute the risk equally.

However, several investment firms he approached declined.

"Well, let's give it a try." Li Xiyuan's eyes gleamed with determination.

If even a high-risk venture like Xinhe Pharmaceutical dared to invest, involving hundreds of millions of yuan, then why shouldn't he?

Thus, he glanced at the contact number for Chenyuan Investment and dialed it directly.